(Q40423172)

20 September 2017

1 reference

title

Brief overview of control of genetic expression by antisense oligonucleotides and in vivo applications. Prospects for neurobiology (English)

1 reference

20 September 2017

1 reference

G Zon

1 reference

20 September 2017

language of work or name

1 reference

1 April 1995

1 reference

20 September 2017

published in

Molecular Neurobiology

1 reference

20 September 2017

1 reference

20 September 2017

issue

2-3

1 reference

20 September 2017

page(s)

219-229

1 reference

In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides

20 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02740677

Effect of over-expression of bacterial ribonuclease H on the utility of antisense MYC oligodeoxynucleotides in the monocytic leukemia cell line U937.

21 January 2018

1 reference

12 December 2020

The abnormal p53 proteins expressed in CML cell lines are non-functional

1 reference

12 December 2020

Transcatheter delivery of c-myc antisense oligomers reduces neointimal formation in a porcine model of coronary artery balloon injury

1 reference

12 December 2020

Antisense oligonucleotides to interleukin-4 regulate IgE and IgG2a production by spleen cells from Nippostrongylus brasiliensis-infected rats

1 reference

12 December 2020

Cloning and antisense oligodeoxynucleotide inhibition of a human homolog of cdc2 required in hematopoiesis

1 reference

12 December 2020

Synthesis of phosphorothioate analogues of oligodeoxyribonucleotides and their antiviral activity against human immunodeficiency virus (HIV).

1 reference

12 December 2020

The involvement of "tumor suppressor" p53 in normal and chronic myelogenous leukemia hemopoiesis

1 reference

12 December 2020

Antisense attenuation of Wnt-1 and Wnt-3a expression in whole embryo culture reveals roles for these genes in craniofacial, spinal cord, and cardiac morphogenesis

1 reference

12 December 2020

The mitogenic response of T cells to interleukin-2 requires Raf-1.

1 reference

12 December 2020

An antisense oligodeoxynucleotide that depletes RI alpha subunit of cyclic AMP-dependent protein kinase induces growth inhibition in human cancer cells

1 reference

12 December 2020

Long-term treatment of human immunodeficiency virus-infected cells with antisense oligonucleotide phosphorothioates

1 reference

12 December 2020

Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo

1 reference

12 December 2020

Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus

1 reference

12 December 2020

Use of an antisense oligonucleotide to inhibit expression of a mutated human procollagen gene (COL1A1) in transfected mouse 3T3 cells

1 reference

12 December 2020

In vivo inhibition of duck hepatitis B virus replication and gene expression by phosphorothioate modified antisense oligodeoxynucleotides.

1 reference

12 December 2020

Antisense oligonucleotides specific for regulatory factor RFX-1 inhibit inducible but not constitutive expression of all major histocompatibility complex class II genes

1 reference

12 December 2020

Biologic and therapeutic significance of MYB expression in human melanoma

1 reference

12 December 2020

Antisense inhibition of the p65 subunit of NF-kappa B blocks tumorigenicity and causes tumor regression

1 reference

12 December 2020

Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cells

1 reference

12 December 2020

Oligonucleotide analogues as potential chemotherapeutic agents

1 reference

12 December 2020

Antisense oligonucleotide of c-myc discriminates between zinc- and dexamethasone-induced synthesis of metallothionein

1 reference

12 December 2020

Inhibition of axonal growth by SNAP-25 antisense oligonucleotides in vitro and in vivo

1 reference

12 December 2020

Antisense inhibition of AT1 receptor mRNA and angiotensinogen mRNA in the brain of spontaneously hypertensive rats reduces hypertension of neurogenic origin

1 reference

12 December 2020

BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death.

1 reference

12 December 2020

Inhibition of neural crest cell attachment by integrin antisense oligonucleotides

1 reference

12 December 2020

Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide

1 reference

12 December 2020

Inhibition of HIV-1 replication in cultured cells with antisense oligonucleotides encapsulated in immunoliposomes.

1 reference

12 December 2020

Comparative inhibition of chloramphenicol acetyltransferase gene expression by antisense oligonucleotide analogues having alkyl phosphotriester, methylphosphonate and phosphorothioate linkages

1 reference

12 December 2020

Disposition of the 14C-labeled phosphorothioate oligonucleotide ISIS 2105 after intravenous administration to rats.

1 reference

12 December 2020

Antisense BCR-ABL oligonucleotides induce apoptosis in the Philadelphia chromosome-positive cell line BV173.

1 reference

12 December 2020

Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides

1 reference

12 December 2020

Stability, clearance, and disposition of intraventricularly administered oligodeoxynucleotides: implications for therapeutic application within the central nervous system

1 reference

12 December 2020

Selective cytotoxicity to human leukemic myeloblasts produced by oligodeoxyribonucleotide phosphorothioates complementary to p53 nucleotide sequences.

1 reference

12 December 2020

Phosphorothioate oligonucleotides: chemistry, purification, analysis, scale-up and future directions

1 reference

12 December 2020

Gene-mimetic substances: drugs designed to intervene in gene expression

1 reference

12 December 2020

Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia

1 reference

12 December 2020

Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

1 reference

12 December 2020

Effects of human papillomavirus type 18-specific antisense oligonucleotides on the transformed phenotype of human carcinoma cell lines

1 reference

12 December 2020

Antisense oligodeoxynucleotide inhibits D2 dopamine receptor-mediated behavior and D2 messenger RNA.

1 reference

12 December 2020

Ablation of transplanted HTLV-I Tax-transformed tumors in mice by antisense inhibition of NF-kappa B

1 reference

12 December 2020

Inhibition of vesicular stomatitis virus protein synthesis and infection by sequence-specific oligodeoxyribonucleoside methylphosphonates

1 reference

12 December 2020

Antisense c-myc effects on preimplantation mouse embryo development

1 reference

12 December 2020

Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions

1 reference

12 December 2020

Gephyrin antisense oligonucleotides prevent glycine receptor clustering in spinal neurons.

1 reference

12 December 2020

C-fos antisense in the nucleus accumbens blocks the locomotor stimulant action of cocaine

1 reference

12 December 2020

Inhibition of Rev activity and human immunodeficiency virus type 1 replication by antisense oligodeoxynucleotide phosphorothioate analogs directed against the Rev-responsive element

1 reference

12 December 2020

Antisense technology: biological utility and practical considerations

1 reference

12 December 2020

Antisense phosphorothioate oligodeoxynucleotides targeted to the vpr gene inhibit human immunodeficiency virus type 1 replication in primary human macrophages

1 reference

12 December 2020

Preparation of 35S-labeled polyphosphorothioate oligodeoxyribonucleotides by use of hydrogen phosphonate chemistry

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02740677

1 reference

Dimensions Publication ID

20 September 2017

1042470955

0 references

Fatcat ID

release_vcfqmndzbrgfnh3vfm5xhbmloy

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vcfqmndzbrgfnh3vfm5xhbmloy

24 November 2022

mapped directly with Wikidata item

1 reference